Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

DEPO:US

20.7600 USD 0.5100 2.52%

As of 20:10:00 ET on 05/22/2015.

Company Profile for Depomed Inc (DEPO)

DepoMed, Inc. develops new and proprietary oral drug delivery technologies. The Company has developed a system designed to be retained in the stomach for an extended period of time while it delivers the incorporated drug or drugs. DepoMed has also developed a system designed to reduce gastrointestinal irritation.

Contact Information

Depomed Inc

7999 Gateway Blvd
Suite 300
Newark, CA 94560
United States
Phone: 510-744-8000

Key Executives for Depomed Inc (DEPO)

James A Schoeneck "Jim"President/CEOAugust J MorettiSenior VP/CFO/Investor Relations
Richard Scott ShivelySenior VP/Chief Commercial OfcrSrinivas G RaoSenior VP/Chief Medical Officer
Matthew M GoslingSenior VP/General CounselThadd M VargasSenior VP:Business Dev
Jeff P CoonVP:Human ResourcesGerd G KochendoerferVP:Technical Dev & Quality

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil